Kinross Gold Corp. is primarily involved in the exploration and operation of gold mines and also is a leading gold mining company globally. The company's operations are located in three core regions: the Americas and West Africa. It holds major assets in Canada, the United States and Russia, and is primarily involved in the exploration and operation of gold mines. Kinross also produces and sells silver. It runs several mines, including Fort Knox, Round Mountain and Kettle River-Buckhorn in the United States, Dvoinoye and Kupol in Russia, Maricunga in Chile, and Paracatu in Brazil. The company's development projects include La Coipa in Chile and Tasiast in Mauritania. Kinross acquired subsidiary, Kinross Brasil Mineracao and hydroelectric power plants (Barra dos Coqueiros and Cacu) located in Brazil from a subsidiary of Gerdau SA. Moreover, strategic investment in core asset will further enhance and strengthen Paracatu, which is a cornerstone asset in the company's portfolio....
+See MoreSharpe-Lintner-Black CAPM alpha (Premium Members Only) Fama-French (1993) 3-factor alpha (Premium Members Only) Fama-French-Carhart 4-factor alpha (Premium Members Only) Fama-French (2015) 5-factor alpha (Premium Members Only) Fama-French-Carhart 6-factor alpha (Premium Members Only) Dynamic conditional 6-factor alpha (Premium Members Only) Last update: Saturday 26 September 2026
2027-01-31 12:25:00 Sunday ET

In recent decades, many governments have chosen to run high fiscal deficits on top of sovereign debt mountains so that greater government intervention still
2020-07-19 09:25:00 Sunday ET

Senior business leaders can learn much from the lean production system with iterative continuous improvements at Toyota. Takehiko Harada (2015)
2023-01-03 09:34:00 Tuesday ET

USPTO fintech patent protection and accreditation As of early-January 2023, the U.S. Patent and Trademark Office (USPTO) has approved
2019-02-28 20:44:00 Thursday ET

AYA Analytica finbuzz podcast channel on YouTube February 2019 In this podcast, we discuss several topical issues as of February 2019: (1) our proprieta
2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be
2019-04-30 19:46:00 Tuesday ET

AYA Analytica finbuzz podcast channel on YouTube April 2019 In this podcast, we discuss several topical issues as of April 2019: (1) Our proprietary